Source:http://linkedlifedata.com/resource/pubmed/id/15782419
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-6
|
pubmed:abstractText |
We present a patient with tremor-dominant hemiparkinsonism after a focal lesion to the substantia nigra. An excellent response to levodopa was complicated by rapid development of motor fluctuations and disabling dyskinesias. Stereotactic thalamotomy resulted in a persistent extinction of parkinsonism and of dyskinesias along with stopping dopaminergic treatment.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0885-3185
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2005 Movement Disorder Society.
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
759-62
|
pubmed:dateRevised |
2007-2-20
|
pubmed:meshHeading |
pubmed-meshheading:15782419-Adult,
pubmed-meshheading:15782419-Antiparkinson Agents,
pubmed-meshheading:15782419-Dyskinesia, Drug-Induced,
pubmed-meshheading:15782419-Female,
pubmed-meshheading:15782419-Humans,
pubmed-meshheading:15782419-Levodopa,
pubmed-meshheading:15782419-Magnetic Resonance Imaging,
pubmed-meshheading:15782419-Parkinsonian Disorders,
pubmed-meshheading:15782419-Substantia Nigra
|
pubmed:year |
2005
|
pubmed:articleTitle |
Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
|
pubmed:affiliation |
Movement Disorders Center, 1st Medical Faculty, Charles University, Katerinská 30, CZ-120 100 Prague, Czech Republic. eruzi@lf1.cuni.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|